Ingevity (NGVT): Director Acquires 414 DSUs; Holdings 5,655 Shares
Francis David Segal, a director of Ingevity Corp (NGVT), reported acquiring 414 vested deferred stock units on 10/01/2025 at a recorded price of $54.44 per share equivalent.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Francis David Segal, a director of Ingevity Corp (NGVT), reported acquiring 414 vested deferred stock units on 10/01/2025 at a recorded price of $54.44 per share equivalent. These DSUs were elected in lieu of quarterly director fees and will convert into an equal number of common shares when Mr. Segal leaves board service under the company's Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan. After this transaction, his reported beneficial ownership is 5,655 shares, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 414 | $54.44 | $23K |
Footnotes (1)
- F1. Represents vested deferred stock units ("DSUs") granted pursuant to the reporting person's election to receive DSUs in lieu of quarterly director fees. These DSUs will settle into an equal number of shares of the Company's Common Stock upon the reporting person's termination of board service pursuant to the Company's Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Ingevity director Francis David Segal report on Form 4 (NGVT)?
Why were deferred stock units (DSUs) issued to the director?
When will the reported DSUs settle into common stock?
Who signed the Form 4 on behalf of Francis David Segal and when?
AI-generated analysis. How Rhea-AI works. Not financial advice.